NEWS AND UPDATES
IHS Passes Rigorous Audit for World-Wide Distribution of its Insignis™ Infusion System
Innovative Health Sciences has successfully secured the exclusive Medical Device Regulations Quality Management System Certificate from BSI (CE MDR QMS), a leading notified body, thus facilitating the introduction of the Insignis™ Infusion System into the world...
IHS Expands Team to Market Insignis™ Syringe Infusion System after Receiving FDA Clearance
CHESTER, N.Y., Aug. 5, 2024 /PRNewswire/ -- Innovative Health Sciences ("IHS" or the "Company"), a medical device company that creates state-of-the-art drug infusion solutions, announced today the expansion of its commercialization team to market the Insignis™ Syringe...
Innovative Health Sciences Receives FDA Clearance for Insignis™ Subcutaneous Needle Sets
CHESTER, N.Y. (August 26, 2021) – Innovative Health Sciences, LLC (“IHS” or the “Company”) management announced today that IHS has received FDA clearance for its Insignis™ Subcutaneous Needle Sets. This regulatory clearance allows IHS to sell and distribute its...